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Abstract
Objectives To evaluate potential relationship between qualitative CT features, quantitative texture analysis (QTA), histology, 
WHO staging, Masaoka classification and myasthenic syndrome in patients with thymic tumors.
Materials and methods Sixteen patients affected by histologically proven thymic tumors were retrospectively included in 
the study population. Clinical information, with special regard to myasthenic syndrome and serological positivity of anti-
AchR antibodies, were recorded. Qualitative CT evaluation included the following parameters: (a) location; (b) tumor edges; 
(c) necrosis; (d) pleural effusion; (e) metastases; (f) chest wall infiltration; (g) tumor margins. QTA included evaluation of 
“Mean” (M), “Standard Deviation” (SD), “Kurtosis” (K), “Skewness” (S), “Entropy” (E), “Shape from Texture” (TX_sigma) 
and “average of positive pixels” (MPP). Pearson–Rho test was used to evaluate the relationship of continuous non-dichotomic 
parameters, whereas Mann–Whitney test was used for dichotomic parameters.
Results Histological evaluation demonstrated thymoma in 12 cases and thymic carcinoma in 4 cases. Tumor necrosis was 
significantly correlated with QTA Mean (p = 0.0253), MPP (p = 0.0417), S (p = 0.0488) and K (p = 0.0178). WHO stag-
ing was correlated with Mean (p = 0.0193), SD (p = 0.0191) and MPP (p = 0.0195). Masaoka classification was correlated 
with Mean (p = 0.0322), MPP (p = 0.0315), skewness (p = 0.0433) and Kurtosis (p = 0.0083). Myasthenic syndrome was 
significantly associated with Mean (p = 0.0211) and MPP (p = 0.0261), whereas tumor size was correlated with Mean 
(p = 0.0241), entropy (p = 0.0177), MPP (p = 0.0468), skewness (p = 0.009) and Kurtosis (p = 0.006).
Conclusion Our study demonstrates significant relationship between radiomics parameters, histology, grading and clinical 
manifestations of thymic tumors.
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Introduction
The aim of radiomics is to evaluate the potential relationship 
between image and biological features of solid tumors [1] 
in order to access prognostic information before treatment 
and optimize therapeutic strategies. This approach has been 
recently applied to various tumors, such as glioblastoma 
[2–4], clear-cell renal carcinoma [5, 6], breast, rectal and 
lung adenocarcinoma [7–11]. Recent studies also demon-
strated how quantitative texture analysis (QTA) may be 
used to complement conventional imaging features [12–17]; 
however, further investigations are needed to deepen the 
knowledge on the relationship between radiological and 
biological phenotypes and to enlarge the role of radiomics 
in clinical practice. The last National Cancer Institute (NCI) 
workshop report [1] proposed several fields of application 
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for radiomics, identifying lung CT as the first research area 
in the priority list, but even less common lesions, such as 
thymic tumors, can represent interesting fields of applica-
tion. The primary objective of this study was to evaluate 
the potential relationship between CT features, QTA data, 
histologic grading and tumor staging in patients with thymic 
tumors [18]; secondly, we assessed the ability of CT and 
QTA to predict the development of a myasthenic syndrome 
and serological positivity of anti-AchR antibodies.
Materials and methods
Patient population
This retrospective study received local Institutional Review 
Board approval; informed consent was obtained for all 
patients or relatives. Data from sixteen patients affected by 
thymic neoplasm were retrospectively retrieved from our 
local clinical database, according to the following inclusion 
criteria: (a) histologic diagnosis of thymic tumor obtained 
with percutaneous image-guided biopsy, mediastinoscopy 
or surgery; (b) tumor classification according to WHO and 
Masaoka systems; (c) CT scan data available for qualitative 
and QTA analysis; (d) no previous chemotherapy or radia-
tion therapy; and (e) available clinical information includ-
ing data on potential myasthenic syndrome and anti-AchR 
antibodies.
CT scan protocol
All CT scans were performed with a 64-slice CT scanner 
(SOMATOM Definition, Siemens, Forchheim—Germany) 
before and after intravenous administration of iodinated 
contrast agent (0.2 mg/kg of Iomeron 400 mgI/ml—Bracco 
SpA—Italy) in the venous phase (60 s delay after contrast 
injection). Images were acquired and reconstructed with the 
following parameters: tube rotation time 0.5 s, collimation 
64 × 0.6, 1 and 3 mm slice thickness, reconstruction interval 
1 and 3 mm, tube voltage 120 kV and tube current 200 mA.
Image analysis
Two radiologists with 8 years and 2 years of experience 
in chest CT, blinded to personal, clinical and histological 
data, independently performed a qualitative evaluation of the 
images. Any difference in interpretation was resolved with 
a consensus reading. QTA was performed by a third inde-
pendent radiologist with 3 years of experience in advanced 
oncologic imaging.
Qualitative evaluation
The two observers were asked to evaluate qualitative CT fea-
tures of thymic tumors, including: (a) location of the lesion, 
recorded as upper mediastinum and lower mediastinum (b) 
lesion edges, recorded as regular or irregular; (c) presence 
or absence of necrosis; (d) presence or absence of pleural 
effusion; (e) presence or absence of distant metastases; (f) 
infiltration of the chest wall, whether present or absent; and 
(g) lesion margins, described as sharp or irregular.
Quantitative texture analysis (QTA)
QTA was performed with TexRAD (TexRAD Ltd, Somer-
set, England, UK). Regions of interest (ROIs) were manu-
ally delineated around the thymic tumor on axial contrast-
enhanced CT images, enclosing only tumor tissue [17, 19] 
as previously described. QTA included an image filtration-
histogram technique followed by quantification of texture 
within the filtered images. The in-plane filtration step uti-
lized a Laplacian of Gaussian spatial band-pass filter to 
produce a series of derived images highlighting features at 
different anatomic spatial scales varying from fine texture 
(SSF2, 2 mm in radius), medium texture (SSF3, 3 mm in 
radius) and coarse texture (SSF4, 4 mm in radius). Hetero-
geneity within ROIs (Fig. 1) was quantified with and without 
image filtration using the following histogram parameters, 
as previously described [20]:
Fig. 1  ROI positioning on CECT and texture elaboration with different spatial scale filter (SSF): fine texture, medium texture and coarse texture
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• Mean (M), which measures the average brightness in 
selected pixels.
• Standard deviation (SD), which measures variation or 
dispersion that exists from the mean.
• Kurtosis (K): from the Greek ‘kyrtosis,’ convexity, which 
measures peakedness and tailedness inversely related to 
the number of features highlighted (whether bright or 
dark); it increases by intensity variations in highlighted 
features.
• Skewness (S), which measures asymmetry in pixel distri-
bution related to the average brightness of the highlighted 
features (predominantly bright features give positive val-
ues, predominantly dark objects give negative values); it 
tends to zero with increasing number of features high-
lighted and moves away from zero with density variation 
in highlighted features.
• Entropy (E), which measures texture irregularity in terms 
of randomness of gray-levels distribution inside the ROI.
• Shape from texture (TX_sigma): parameter dealing with 
information on the geometric surface of the lesion.
• MPP, average of positive pixels.
Statistical analysis
In this study, the normality of each continuous variable 
group was tested using the Kolmogorov–Smirnov Z test. 
Continuous data were described as the mean value ± SD, 
whereas non-continuous data with median and 2.5 and 97.5 
percentiles. Spearman test was used to evaluate the cor-
relation between QTA variables and WHO/Masaoka clas-
sification, MG and size. Mann–Whitney test was used for 
dichotomic parameters. A p value < 0.05 was regarded to 
indicate statistically significant association. All p values 
were calculated using a two-tailed significance level. R 
software (www.r-proj ect.org) was employed for statistical 
analyses (version 3.1.3 “Smooth Sidewalk”, R Foundation 
for Statistical Computing, Vienna, Austria).
Results
General results
Fifteen out of 16 patients underwent surgery; 1 patient was 
judged unresectable and therefore underwent chemotherapy. 
Histological examination demonstrated thymoma in 12 cases 
and thymic carcinoma in 4 cases. The average maximum 
diameter of the tumors was 54.43 mm (range 115–15 mm). 
According to the WHO score, patients were classified as fol-
lows: WHO B1: 1 patient; WHO B2: 7 patients; WHO B3: 
4 patients; WHO C: 4 patients. According to the Masaoka 
staging system, patients were classified as follows: Masaoka 
I: 3 patients; Masaoka II: 7 patients; Masaoka III: 2 patients; 
Masaoka IV: 4 patients. Myasthenic syndrome was present 
in 7 out of 16 patients (5 WHO B2, 1 B3 and 1 C), with 
6 of them being positive for anti-AchR antibodies; among 
the remaining 9 patients, one was positive for anti-AchR 
antibodies.
Qualitative analysis
Tumor location was in the upper mediastinum in 13 cases 
and lower mediastinum in 3 cases lesion. Lesion edges 
were regular in 15 patients and irregular in 1 patient. Tumor 
necrosis was present in 8 patients and absent in 8 patients. 
Pleural effusion was present in 3 patients and absent in 13 
patients. Metastasis was present in 4 patients and absent in 
12 patients. Infiltration of the chest wall was present in 1 
patient and absent in 15 patients. Tumor margins were well 
defined in 13 patients and not defined in 3 patients. Due to 
the small sample size included in this preliminary study, 
necrosis was the only parameter which could be analyzed 
for relationship with the QTA data using the Mann–Whitney 
test, (Table 1).
Quantitative analysis
To assess whether the sample data analysis had a Gaussian 
trend, the Kolmogorov–Smirnov Z test was used (Table 2). 
Results derived from the relationship between quantitative 
parameters, staging systems and clinical features are sum-
marized in Table 3; significant associations were observed 
between: WHO and mean (p = 0.0193), SD (p = 0.0191) 
and MPP (p  =  0.0195) (Fig.  2); Masaoka and mean 
(p = 0.0322), MPP (p = 0.0315), skewness (p = 0.0433) 
and kurtosis (p = 0.0083) (Fig. 3). Myasthenic syndrome 
was significantly associated with mean (p = 0.0211) and 
MPP (p = 0.0261), whereas size was correlated with mean 
(p = 0.0241), entropy (p = 0.0177), MPP (p = 0.0468), 
skewness (p = 0.009) and kurtosis (p = 0.006) (Fig. 4).
Table 1  Mann–Whitney test 
results for relationship between 
QTA parameters and necrosis
Parameter Mann–
Whitney U 
test
Test Z
TX sigma 45 0.902
Mean 25 2.37
SD 32 1.77
Entropy 36 1.503
MPP 28 2.037
Skewness 29 1.97
Kurtosis 23 2.371
Total 25 2.204
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Table 2  Kolmogorov–Smirnov Z test results
Mean 95% CI Median 95% CI 2.5–97.5 P K–S zeta test
TX_sigma 1.037 0.983–1.092 1.033 0.978–1.089 0.819–1.314 0.8133
Mean 149.064 83.668–214.460 74.637 47.407–173.219 11.116–530.897 0.0278*
SD 175.778 142.058–209.499 162.24 114.804–213.059 78.912–325.260 0.399
Entropy 5.235 5.063–5.407 5.292 5.102–5.436 3.959–5.841 0.0001*
MPP 197.308 136.422–258.193 148.25 100.209–217.071 62.671–540.726 0.0334*
Skewness 1.34 0.917–1.763 1.274 0.658–1.974 − 0.411–3.685 0.5401
Kurtosis 6.482 3.546–9.417 4.416 3.001–10.130 − 0.0722–28.822 < 0.0001*
Total 1760.136 1010.320–2509.952 1069 433.764–2357.046 61.850–5017.000 0.146
Table 3  Pearson–Rho test results for relationship between quantitative parameters, staging systems and clinical features
TX_sigma Mean SD Entropy MPP Skewness Kurtosis Total
WHO Rho value − 0.321 − 0.495 − 0.495 0.12 − 0.494 0.212 0.33 0.23
p value 0.1448 0.0193* 0.0191* 0.5961 0.0195* 0.3442 0.134 0.3028
Masaoka Rho value − 0.36 − 0.458 − 0.413 0.169 − 0.459 0.434 0.548 0.332
p value 0.0999 0.0322* 0.0562 0.4509 0.0315* 0.0433* 0.0083* 0.1308
MG Rho value 0.188 0.488 0.466 − 0.353 0.473 − 0.143 − 0.188 − 0.331
p value 0.4025 0.0211* 0.0289* 0.1069 0.0261* 0.5262 0.403 0.1327
SIZE Rho value − 0.014 − 0.479 − 0.315 0.501 − 0.428 0.543 0.566 0.664
p value 0.9503 0.0241* 0.1538 0.0177* 0.0468* 0.009* 0.006* 0.0007*
Fig. 2  Relationships data between QTA and WHO classification
Fig. 3  Most significative rela-
tionship data between QTA and 
Masaoka staging system
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Discussion
The objective of this study was to evaluate the potential rela-
tionship of QTA with several clinical and imaging param-
eters in patients with thymic neoplasm. The identification 
of these relationships could derive noninvasive prognostic 
information before treatment and predict the occurrence of 
certain clinical scenarios, with possible impact on treatment 
decisions and patient management. Qualitative imaging 
features may represent immediate tools, potentially useful 
for the radiologist during reporting; unfortunately, in this 
preliminary study, the small number of patients enrolled 
allowed only a partial analysis, concerning only one quali-
tative parameter (necrosis). In particular, the association 
between necrosis and QTA parameters, such as kurtosis 
and skewness, was expected, since these two parameters 
represent the lack of homogeneity of the pixels and the 
deviation from normality, respectively. In any case, the 
finding of significant associations in this preliminary analy-
sis looks promising; in the next future, a more extensive 
analysis including a higher number of patients and CT fea-
tures is likely to reveal further associations. On the other 
hand, several significant relationships were demonstrated 
between QTA parameters, classification systems used for 
thymic lesions (WHO and Masaoka), tumor size and clini-
cal condition; these associations can be explained basing on 
intrinsic features of tumors; for example, basing on entropy, 
whose values  increase as size increases, we can infer that 
larger tumors have a less homogeneous pixel distribution; 
this observation is confirmed by the trend of MPP, which 
decreases with increasing tumor size, indicating a more 
homogeneous appearance in smaller tumors. These asso-
ciations, particularly between QTA data and classification 
systems, seem also to indirectly suggest a relationship with 
prognosis, since these classifications have prognostic sig-
nificance, especially the Masaoka system, already validated 
as independent prognostic factor [18]. Even in this case, the 
enrollment of more patients in a further study could allow a 
survival analysis, with the aim to assess the presence of an 
effective direct relationship between QTA parameters and 
clinical outcome. The relationship between QTA parameters 
and histology also represents an incentive for further studies, 
with the aim to correlate phenotypic and genotypic features 
of the tumor, as already done for other cancers, such as glio-
blastoma multiforme or lung adenocarcinoma. Furthermore, 
the ability to differentiate different components of the tumor 
through imaging analysis could also encourage the use of 
these techniques of radiomics and quantitative analysis as 
biopsy guidance, in order to identify the most suitable areas 
of the tumor to be sampled. Finally, the relationship between 
imaging data and the clinical scenario could confer the abil-
ity to predict the potential onset of symptoms and then to 
lead to a more straightforward patient management.
The greatest limitation of this work is represented by 
the small size of the examined sample: anyway, this in a 
preliminary study and these relationships need to be con-
firmed in larger studies, taking into account a larger num-
ber of patients and variables.
In conclusion, the identification of significant associa-
tions between radiological phenotype (including qualita-
tive and quantitative evaluation), histological type, stag-
ing and clinical picture highlights the usefulness of this 
approach, whose main aim is to identify imaging features 
representing potential biological markers of the tumor, 
with consequent clinical and prognostic implications.
Fig. 4  Relationship data between QTA and lesion size
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